Adult Still’s disease is a relatively rare form of rheumatoid arthritis with systemic inflammatory features. The prevalence is around 1.5 cases per 100,000 - 1000,000. In the current case we display a 30-year-old mal...Adult Still’s disease is a relatively rare form of rheumatoid arthritis with systemic inflammatory features. The prevalence is around 1.5 cases per 100,000 - 1000,000. In the current case we display a 30-year-old male patient with refractory adult still’s disease who suffered recurrent attacks of fever 39.5°C, arthritis in proximal interphalangeal joints (PIPs), wrists, tempromandibular joints (TMJs), knees and ankles, stitching chest pain, dyspnea, erythematous rash over the trunk, sore throat, weight loss (15 Kilograms in 4 months). The patients’ disease remained uncontrolled despite of synthetic disease modifying anti-rheumatic drugs and repeated intramuscular corticosteroid injections. Laboratory workup revealed erythrocyte sedimentation rate (ESR) of 95, C-reactive protein (CRP) of 100 mg/L, hemoglobin 10.5 gm%, leukocytosis 12,000/microlitre, mild elevation of liver function tests and dyslipidemia. Serology revealed negative rheumatoid factor, anti-nuclear antibody titre of 1:80, elevated serum ferritin 4000 micrograms/litre. The patient was started on rituximab (375 mg/m2), prednisolone 20 mg/day and selective Cox-2 inhibitor. Follow up for over three months following the completion of his pulse therapy, revealed no relapse of fever or fatigue, with morning stiffness of 5 - 10 minutes, VAS of 3, DAS28 of 3.8, HAQDI of 0.62, ESR 23, CRP 4.9, Hb 12.5 gm%, leucocytic count 9000/microlitre, the dose of prednisolone was successfully reduced to a dose of 5 mg/day orally. Conclusion: Anti-CD20 therapy successfully controlled systemic and articular refractory disease with sustained efficacy over a follow up period of up to 24 weeks.展开更多
BACKGROUND Juvenile systemic lupus erythematosus(SLE)is a severe,life-threatening disease.However,the role of rituximab in managing juvenile SLE remains undefined,although early biological intervention may improve dis...BACKGROUND Juvenile systemic lupus erythematosus(SLE)is a severe,life-threatening disease.However,the role of rituximab in managing juvenile SLE remains undefined,although early biological intervention may improve disease outcomes.AIM To assess the differences in the outcomes of different types of rituximab administration(early and late).METHODS In this retrospective cohort study,the information of 36 children with SLE with administration(LRA)was analyzed.We compared initial disease characteristics at onset,at baseline(start of rituximab),and at the end of the study(EOS)at 12 months,as well as outcomes and treatment characteristics.RESULTS The main differences at baseline were a higher daily median dose of corticosteroids,increased MAS frequency,and a higher Systemic Lupus Erythematosus Disease Activity Index(SLEDAI)in the ERA group.No differences in the main SLE outcomes between groups at the EOS were observed.The part of lupus nephritis patients who achieved remission changed from 44%to 31%in ERA and 32%to 11%in the LRA group.Patients with ERA had a shorter time to achieve low daily corticosteroid dose(≤0.2 mg/kg)at 1.2(0.9;1.4)years compared to 2.8(2.3;4.0)years(P=0.000001)and higher probability to achieve this low dose[hazard ratio(HR)=57.8(95%confidence interval(CI):7.2-463.2),P=0.00001 and remission(SLEDAI=0);HR=37.6(95%CI:4.45-333.3),P=0.00001].No differences in adverse events,including severe adverse events,were observed.CONCLUSION ERA demonstrated a better steroid-sparing effect and a possibility of earlier remission or low disease activity,except for lupus nephritis.Further investigations are required.展开更多
Objective:The aim of our study was to investigate the value of CT/CT image fusion radiation treatment planning in non-small cell lung cancer(NSCLC) and the impact on V20 and radiation pneumonitis(RP).Methods:Patients ...Objective:The aim of our study was to investigate the value of CT/CT image fusion radiation treatment planning in non-small cell lung cancer(NSCLC) and the impact on V20 and radiation pneumonitis(RP).Methods:Patients who were pathologically or cytologically diagnosed of stage IIIA and IIIB NSCLC were treated with three-dimensional conformal radiation therapy(4000 cGy).Forty patients got at least 25% tumor reduction were randomly divided into two groups:group A of regular shrink field radiotherapy(20 cases) and group B of CT/CT image fused shrink field radiotherapy(20 cases).Dosage reached 6600 cGy.Clinical data,V20 and RP were observed within 3 months after radiotherapy.Statistical analysis was conducted for the NSCLC patients.Results:22.5%(9/40) patients got RP during follow-up.Group A accounted for 6 cases(30%),and group B had 3 cases(15%).There was no marked difference between the two groups(P = 0.256),univariate analysis revealed that the IV20 of A and B groups,and IV20 and CV20 of all patients were statistically related to the incidence of RP(P < 0.05).With Wilcoxon method assay,the ipsilateral lung V20 and contralateral lung V20 had statistical significance between the two groups(P < 0.05).Conclusion:The CT/CT image infusion treatment planning could increase the radical dosage with better tumor control probability but won't increase adverse reaction.展开更多
目的:探讨不同剂量20%氨基酮戊酸光动力治疗外阴尖锐湿疣患者的疗效。方法:将2013年5月至2015年10月我院收治的76例外阴尖锐湿疣患者随机分为观察组(40例)和对照组(36例),观察组采用0.5m L 20%氨基酮戊酸光动力治疗,对照组采用0.25m L ...目的:探讨不同剂量20%氨基酮戊酸光动力治疗外阴尖锐湿疣患者的疗效。方法:将2013年5月至2015年10月我院收治的76例外阴尖锐湿疣患者随机分为观察组(40例)和对照组(36例),观察组采用0.5m L 20%氨基酮戊酸光动力治疗,对照组采用0.25m L 20%氨基酮戊酸光动力治疗,比较两组临床疗效、疣体清除、治疗后复发及不良反应发生情况。结果:观察组1、2、3次治疗后总有效率分别为75.0%、95.0%及97.5%,明显高于对照组的47.2%、69.4%及77.8%,差异均有统计学意义(P<0.05);观察组治疗1、2、3周疣体清除率分别为76.9%、94.2%及96.2%,明显高于对照组的45.7%、73.9%及82.6%,差异有统计学意义(P<0.05);观察组治疗后12周及24周复发率均为10.0%,明显低于对照组的30.6%、33.3%,差异有统计学意义(P<0.05);观察组不良反应发生率为27.5%,对照组为33.3%,比较差异无统计学意义(P>0.05)。结论:0.5m L 20%氨基酮戊酸光动力较0.25m L20%氨基酮戊酸光动力治疗外阴尖锐湿疣更有助于清除疣体,降低复发,且未增加不良反应,疗效显著,值得在临床上推广应用。展开更多
The article introduces Prof.Weijia’s experience in using Fengchi(GB 20)totreat gastric ulcer,bronchial asthma,sciatica,and alopecia,etc.He considers that the point has seven general functions of dispelling pathogenic...The article introduces Prof.Weijia’s experience in using Fengchi(GB 20)totreat gastric ulcer,bronchial asthma,sciatica,and alopecia,etc.He considers that the point has seven general functions of dispelling pathogenic wind,purging pathogenic fire,relieving the depressedliver-Qi,resolving the phlegm,activating the blood,tranquilizing the mind,and checking spasm andconvulsion.It also introduces some common diseases treated with needling Fengchi and adjunctpoints,manipulations,and precautions,etc.It Is a comparatively comprehensive summary of Prof.Wei Jia’s individual experience in wonderfully using Fengchi.展开更多
Acupuncture at Baihui（GV 20）was employed in treating 32 cases of functionalenuresis.As a result,the curative rate reached 81.25％,but that in control group of 32 cases withoutneedling Baihui point was 56.25％.There ...Acupuncture at Baihui（GV 20）was employed in treating 32 cases of functionalenuresis.As a result,the curative rate reached 81.25％,but that in control group of 32 cases withoutneedling Baihui point was 56.25％.There was a significant difference in statistics（P【0.05）.It indi- cates that Baihui can enhance the therapeutic effect of acupuncture on treating enuresis.展开更多
The article introduces the writers’ experience in using Fengchi(GB 20) to treat sciatica,gastric ulcer and bronchial asthma, etc. The writers consider that the point has seven general functions of dispelling pathogen...The article introduces the writers’ experience in using Fengchi(GB 20) to treat sciatica,gastric ulcer and bronchial asthma, etc. The writers consider that the point has seven general functions of dispelling pathogenic wind, purging pathogenic fire, relieving the depressed liver-qi, resolvingthe phlegm, activating the blood, tranquilizing the mind, and checking spasm and c0nvulsion. It alsointroduces the manipulations and precautions of needling Fengchi.展开更多
Objective：To observe the effect of acupuncture of Fengchi （风池 GB 20） on blood pressure, serum IL-6 and plasma endothelin （ET） contents in patients with hypertension. Methods： Thirty cases of hy-pertension pati...Objective：To observe the effect of acupuncture of Fengchi （风池 GB 20） on blood pressure, serum IL-6 and plasma endothelin （ET） contents in patients with hypertension. Methods： Thirty cases of hy-pertension patients were made up of treatment group and treated with acupuncture of Fengchi （GB 20） ; while 20 healthy subjects were made up of control group. Blood pressure was determined before and after the treatment. Fasting blood samples were taken from the cubital venous vessel for detecting serum interleukin （IL）-6 and plasma ET contents with radioimmunoassay before and after acupuncture treatment. Results： Before the treatment, in hypertension patients, serum IL-6 and plasma ET levels were significant higher thanthose in healthy subjects （P〈 0.01 ）; while after the treatment, blood pressure of treatment group declined significantly （ P 〈 0.01 ）, serum IL-6 and plasma ET levels decreased considerably （ P 〈 0.01 ）. Conclusion： Acupuncture of Fengchi （GB 20） can lower blood pressure, regulate cellular immunity and secretion functions of the vascular endothelial cells in hypertension patients.展开更多
目的:观察风池穴水针刀治疗颈源性头痛(cervicogenic headache,CEH)的临床疗效。方法:选取淄博市中西医结合医院针灸科、脑病科2020年3月至2021年4月收治的CEH患者120例,按照随机数字表法分为治疗组、针刺组和西药组,每组40例。针刺组...目的:观察风池穴水针刀治疗颈源性头痛(cervicogenic headache,CEH)的临床疗效。方法:选取淄博市中西医结合医院针灸科、脑病科2020年3月至2021年4月收治的CEH患者120例,按照随机数字表法分为治疗组、针刺组和西药组,每组40例。针刺组给予常规针刺治疗,西药组给予口服双氯芬酸钠肠溶缓释胶囊治疗,治疗组给予风池穴水针刀治疗。观察3组患者治疗前后颈椎活动度(cervical range of motion,ROM)评分、头痛程度评分、头痛持续时间评分、头痛指数评分变化情况,治疗后3个月随访进行远期疗效评价。结果:3组患者治疗后头痛程度评分、头痛持续时间评分、头痛指数评分均低于治疗前,差异有统计学意义(P<0.01),治疗组和西药组治疗1个疗程、2个疗程后头痛程度评分、头痛持续时间评分、头痛指数均低于针刺组,差异有统计学意义(P<0.01),但治疗组与西药组比较,差异无统计学意义(P>0.05)。3组患者治疗1个疗程、治疗2个疗程后ROM评分均低于治疗前,差异有统计学意义(P<0.01),治疗组治疗1个疗程、治疗2个疗程后ROM评分低于针刺组、西药组,差异有统计学意义(P<0.05),针刺组治疗2个疗程后ROM评分低于西药组,差异有统计学意义(P<0.05)。治疗组有效率为87.5%,针刺组有效率为65.0%,西药组有效率为47.5%,治疗组有效率高于西药组、针刺组,差异具有统计学意义(P<0.01)。结论:水针刀风池穴治疗颈源性头痛即时镇痛效果好,远期临床疗效高,能改善患者颈椎活动度。展开更多
文摘Adult Still’s disease is a relatively rare form of rheumatoid arthritis with systemic inflammatory features. The prevalence is around 1.5 cases per 100,000 - 1000,000. In the current case we display a 30-year-old male patient with refractory adult still’s disease who suffered recurrent attacks of fever 39.5°C, arthritis in proximal interphalangeal joints (PIPs), wrists, tempromandibular joints (TMJs), knees and ankles, stitching chest pain, dyspnea, erythematous rash over the trunk, sore throat, weight loss (15 Kilograms in 4 months). The patients’ disease remained uncontrolled despite of synthetic disease modifying anti-rheumatic drugs and repeated intramuscular corticosteroid injections. Laboratory workup revealed erythrocyte sedimentation rate (ESR) of 95, C-reactive protein (CRP) of 100 mg/L, hemoglobin 10.5 gm%, leukocytosis 12,000/microlitre, mild elevation of liver function tests and dyslipidemia. Serology revealed negative rheumatoid factor, anti-nuclear antibody titre of 1:80, elevated serum ferritin 4000 micrograms/litre. The patient was started on rituximab (375 mg/m2), prednisolone 20 mg/day and selective Cox-2 inhibitor. Follow up for over three months following the completion of his pulse therapy, revealed no relapse of fever or fatigue, with morning stiffness of 5 - 10 minutes, VAS of 3, DAS28 of 3.8, HAQDI of 0.62, ESR 23, CRP 4.9, Hb 12.5 gm%, leucocytic count 9000/microlitre, the dose of prednisolone was successfully reduced to a dose of 5 mg/day orally. Conclusion: Anti-CD20 therapy successfully controlled systemic and articular refractory disease with sustained efficacy over a follow up period of up to 24 weeks.
基金Supported by Ministry of Science and Higher Education of the Russian Federation,No.075-15-2022-301the Russian Science Foundation Grant,No.22-45-08004.
文摘BACKGROUND Juvenile systemic lupus erythematosus(SLE)is a severe,life-threatening disease.However,the role of rituximab in managing juvenile SLE remains undefined,although early biological intervention may improve disease outcomes.AIM To assess the differences in the outcomes of different types of rituximab administration(early and late).METHODS In this retrospective cohort study,the information of 36 children with SLE with administration(LRA)was analyzed.We compared initial disease characteristics at onset,at baseline(start of rituximab),and at the end of the study(EOS)at 12 months,as well as outcomes and treatment characteristics.RESULTS The main differences at baseline were a higher daily median dose of corticosteroids,increased MAS frequency,and a higher Systemic Lupus Erythematosus Disease Activity Index(SLEDAI)in the ERA group.No differences in the main SLE outcomes between groups at the EOS were observed.The part of lupus nephritis patients who achieved remission changed from 44%to 31%in ERA and 32%to 11%in the LRA group.Patients with ERA had a shorter time to achieve low daily corticosteroid dose(≤0.2 mg/kg)at 1.2(0.9;1.4)years compared to 2.8(2.3;4.0)years(P=0.000001)and higher probability to achieve this low dose[hazard ratio(HR)=57.8(95%confidence interval(CI):7.2-463.2),P=0.00001 and remission(SLEDAI=0);HR=37.6(95%CI:4.45-333.3),P=0.00001].No differences in adverse events,including severe adverse events,were observed.CONCLUSION ERA demonstrated a better steroid-sparing effect and a possibility of earlier remission or low disease activity,except for lupus nephritis.Further investigations are required.
文摘Objective:The aim of our study was to investigate the value of CT/CT image fusion radiation treatment planning in non-small cell lung cancer(NSCLC) and the impact on V20 and radiation pneumonitis(RP).Methods:Patients who were pathologically or cytologically diagnosed of stage IIIA and IIIB NSCLC were treated with three-dimensional conformal radiation therapy(4000 cGy).Forty patients got at least 25% tumor reduction were randomly divided into two groups:group A of regular shrink field radiotherapy(20 cases) and group B of CT/CT image fused shrink field radiotherapy(20 cases).Dosage reached 6600 cGy.Clinical data,V20 and RP were observed within 3 months after radiotherapy.Statistical analysis was conducted for the NSCLC patients.Results:22.5%(9/40) patients got RP during follow-up.Group A accounted for 6 cases(30%),and group B had 3 cases(15%).There was no marked difference between the two groups(P = 0.256),univariate analysis revealed that the IV20 of A and B groups,and IV20 and CV20 of all patients were statistically related to the incidence of RP(P < 0.05).With Wilcoxon method assay,the ipsilateral lung V20 and contralateral lung V20 had statistical significance between the two groups(P < 0.05).Conclusion:The CT/CT image infusion treatment planning could increase the radical dosage with better tumor control probability but won't increase adverse reaction.
文摘目的:探讨不同剂量20%氨基酮戊酸光动力治疗外阴尖锐湿疣患者的疗效。方法:将2013年5月至2015年10月我院收治的76例外阴尖锐湿疣患者随机分为观察组(40例)和对照组(36例),观察组采用0.5m L 20%氨基酮戊酸光动力治疗,对照组采用0.25m L 20%氨基酮戊酸光动力治疗,比较两组临床疗效、疣体清除、治疗后复发及不良反应发生情况。结果:观察组1、2、3次治疗后总有效率分别为75.0%、95.0%及97.5%,明显高于对照组的47.2%、69.4%及77.8%,差异均有统计学意义(P<0.05);观察组治疗1、2、3周疣体清除率分别为76.9%、94.2%及96.2%,明显高于对照组的45.7%、73.9%及82.6%,差异有统计学意义(P<0.05);观察组治疗后12周及24周复发率均为10.0%,明显低于对照组的30.6%、33.3%,差异有统计学意义(P<0.05);观察组不良反应发生率为27.5%,对照组为33.3%,比较差异无统计学意义(P>0.05)。结论:0.5m L 20%氨基酮戊酸光动力较0.25m L20%氨基酮戊酸光动力治疗外阴尖锐湿疣更有助于清除疣体,降低复发,且未增加不良反应,疗效显著,值得在临床上推广应用。
文摘The article introduces Prof.Weijia’s experience in using Fengchi(GB 20)totreat gastric ulcer,bronchial asthma,sciatica,and alopecia,etc.He considers that the point has seven general functions of dispelling pathogenic wind,purging pathogenic fire,relieving the depressedliver-Qi,resolving the phlegm,activating the blood,tranquilizing the mind,and checking spasm andconvulsion.It also introduces some common diseases treated with needling Fengchi and adjunctpoints,manipulations,and precautions,etc.It Is a comparatively comprehensive summary of Prof.Wei Jia’s individual experience in wonderfully using Fengchi.
文摘Acupuncture at Baihui（GV 20）was employed in treating 32 cases of functionalenuresis.As a result,the curative rate reached 81.25％,but that in control group of 32 cases withoutneedling Baihui point was 56.25％.There was a significant difference in statistics（P【0.05）.It indi- cates that Baihui can enhance the therapeutic effect of acupuncture on treating enuresis.
文摘The article introduces the writers’ experience in using Fengchi(GB 20) to treat sciatica,gastric ulcer and bronchial asthma, etc. The writers consider that the point has seven general functions of dispelling pathogenic wind, purging pathogenic fire, relieving the depressed liver-qi, resolvingthe phlegm, activating the blood, tranquilizing the mind, and checking spasm and c0nvulsion. It alsointroduces the manipulations and precautions of needling Fengchi.
文摘Objective：To observe the effect of acupuncture of Fengchi （风池 GB 20） on blood pressure, serum IL-6 and plasma endothelin （ET） contents in patients with hypertension. Methods： Thirty cases of hy-pertension patients were made up of treatment group and treated with acupuncture of Fengchi （GB 20） ; while 20 healthy subjects were made up of control group. Blood pressure was determined before and after the treatment. Fasting blood samples were taken from the cubital venous vessel for detecting serum interleukin （IL）-6 and plasma ET contents with radioimmunoassay before and after acupuncture treatment. Results： Before the treatment, in hypertension patients, serum IL-6 and plasma ET levels were significant higher thanthose in healthy subjects （P〈 0.01 ）; while after the treatment, blood pressure of treatment group declined significantly （ P 〈 0.01 ）, serum IL-6 and plasma ET levels decreased considerably （ P 〈 0.01 ）. Conclusion： Acupuncture of Fengchi （GB 20） can lower blood pressure, regulate cellular immunity and secretion functions of the vascular endothelial cells in hypertension patients.
文摘目的:观察风池穴水针刀治疗颈源性头痛(cervicogenic headache,CEH)的临床疗效。方法:选取淄博市中西医结合医院针灸科、脑病科2020年3月至2021年4月收治的CEH患者120例,按照随机数字表法分为治疗组、针刺组和西药组,每组40例。针刺组给予常规针刺治疗,西药组给予口服双氯芬酸钠肠溶缓释胶囊治疗,治疗组给予风池穴水针刀治疗。观察3组患者治疗前后颈椎活动度(cervical range of motion,ROM)评分、头痛程度评分、头痛持续时间评分、头痛指数评分变化情况,治疗后3个月随访进行远期疗效评价。结果:3组患者治疗后头痛程度评分、头痛持续时间评分、头痛指数评分均低于治疗前,差异有统计学意义(P<0.01),治疗组和西药组治疗1个疗程、2个疗程后头痛程度评分、头痛持续时间评分、头痛指数均低于针刺组,差异有统计学意义(P<0.01),但治疗组与西药组比较,差异无统计学意义(P>0.05)。3组患者治疗1个疗程、治疗2个疗程后ROM评分均低于治疗前,差异有统计学意义(P<0.01),治疗组治疗1个疗程、治疗2个疗程后ROM评分低于针刺组、西药组,差异有统计学意义(P<0.05),针刺组治疗2个疗程后ROM评分低于西药组,差异有统计学意义(P<0.05)。治疗组有效率为87.5%,针刺组有效率为65.0%,西药组有效率为47.5%,治疗组有效率高于西药组、针刺组,差异具有统计学意义(P<0.01)。结论:水针刀风池穴治疗颈源性头痛即时镇痛效果好,远期临床疗效高,能改善患者颈椎活动度。
